| Product | Product Type | Antibody Family | Clone | Isotype | Application | Expression System | Host | Affinity Tag | Format | Target Name | Species | Reactivity | Catalog # | Size | Price | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antibodies | Abatacept | N/A | Flow cytometry, animal model study | Liquid | 500001 500002 500003 | 1 mg 5 mg 20 mg | $400 $800 $2200 | |||||||||
Antibodies | Abciximab | Hman IgG1 Fab | Flow cytometry, animal model study | Liquid | 500101 500102 500103 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Adalimumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 500301 500302 500303 | 1 mg 5 mg 20 mg | $125 $400 $800 | |||||||||
Antibodies | Aflibercept | Human IgG1-Fc | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 500401 500402 500403 | 1 mg 5 mg 20 mg | $400 $800 $1600 | |||||||||
Antibodies | Alemtuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 500501 500502 500503 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Atezolizuma | Human IgG1 | Flow cytometry, animal model study | Liquid | 500601 500602 500603 500604 500605 | 5 mg 20 mg 1 mg 5 mg 20 mg | $720 $1440 $175 $480 $960 | |||||||||
Antibodies | Avelumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 500701 500702 500703 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Belatacep | Human IgG1 | Flow cytometry, animal model study | Liquid | 500801 500802 500803 | 1 mg 5 mg 20 mg | $400 $800 $1600 | |||||||||
Antibodies | Bevacizumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 500901 500902 500903 | 1 mg 5 mg 20 mg | $125 $400 $800 | |||||||||
Antibodies | Briakinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 501001 501002 501003 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Brolucizumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 501101 501102 501103 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Camrelizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 501201 501202 501203 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Cemiplimab | Human IgG4 | Flow cytometry, animal model study | Liquid | 501301 501302 501303 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Cetuximab | Human IgG1 | Flow cytometry, animal model study | Liquid | 501401 501402 501403 | 1 mg 5 mg 20 mg | $125 $400 $800 | |||||||||
Antibodies | Clenoliximab | Human IgG4 | Flow cytometry, animal model study | Liquid | 501501 501502 501503 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Cofetuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 501601 501602 501603 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Daclizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 501701 501702 501703 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Daratumumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 501801 501802 501803 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Denosumab | Human IgG2 | Flow cytometry, animal model study | Liquid | 501901 501902 501903 | 1 mg 5 mg 20 mg | $125 $400 $800 | |||||||||
Antibodies | Drozitumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502001 502002 502003 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Dupilumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 502101 502102 502103 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Durvalumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502201 502202 502203 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Eculizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 502301 502302 502303 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Efalizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502401 502402 502403 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Envafolimab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502501 502502 502503 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Epratuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502601 502602 502603 502604 502605 | 1 mg 5 mg 20 mg 5 mg 20 mg | $250 $750 $2000 $750 $3000 | |||||||||
Antibodies | Etanercept | Human IgG1 | Flow cytometry, animal model study | Liquid | 502701 502702 502703 | 1 mg 5 mg 20 mg | $175 $480 $1200 | |||||||||
Antibodies | Evolocumab | Human IgG2 | Flow cytometry, animal model study | Liquid | 502801 502802 502803 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Felvizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 502901 502902 502903 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Galiximab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503001 503002 503003 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Gemtuzumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 503101 503102 503103 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Ifinatamab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503201 503202 503203 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Infliximab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 503301 503302 503303 | 1 mg 5 mg 20 mg | $125 $400 $800 | |||||||||
Antibodies | Ipilimumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503401 503402 503403 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Isatuximab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503501 503502 503503 | 1 mg 5 mg 20 mg | $250 $750 $2500 | |||||||||
Antibodies | Matuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503601 503602 503603 | 1 mg 5 mg 20 mg | $250 $750 $2500 | |||||||||
Antibodies | Minretumomab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503701 503702 503703 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Mogamulizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 503801 503802 503803 | 1 mg 5 mg 20 mg | $250 $750 $2500 | |||||||||
Antibodies | Muromonab | Human IgG2 | Flow cytometry, animal model study | Liquid | 503901 503902 503903 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Nimotuzumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 504101 504102 504103 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Nivolumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 504201 504202 504203 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Obinutuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 504301 504302 504303 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Omalizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 504401 504402 504403 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Palivizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 504501 504502 504503 504504 504505 | 1 mg 5 mg 20 mg 5 mg 20 mg | $175 $480 $960 $720 $1440 | |||||||||
Antibodies | Panitumumab | Human IgG2 | Flow cytometry, animal model study | Liquid | 504601 504602 504603 504604 504605 | 1 mg 5 mg 20 mg 5 mg 20 mg | $175 $480 $960 $720 $1440 | |||||||||
Antibodies | Pembrolizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 504701 504702 504703 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Pertuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 504801 504802 504803 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Polatuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 504901 504902 504903 | 1 mg 5 mg 20 mg | $175 $480 $1200 | |||||||||
Antibodies | Ramucirumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 505001 505002 505003 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Ranibizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 505101 505102 | 2 mg 10 mg | $500 $1250 | |||||||||
Antibodies | Relatlimab | Human IgG4 | Flow cytometry, animal model study | Liquid | 505201 505202 505203 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Rituximab | Human IgG1 | Flow cytometry, animal model study | Liquid | 505301 505302 505303 505304 505305 | 1 mg 5 mg 20 mg 5 mg 20 mg | $125 $400 $800 $600 $1200 | |||||||||
Antibodies | Rovalpituzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 505401 505402 505403 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Sacituzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 505501 505502 505503 505504 505505 | 1 mg 5 mg 20 mg 5 mg 20 mg | $175 $480 $960 $720 $1440 | |||||||||
Antibodies | Secukinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 505601 505602 505603 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Semaglutide | NA | Flow cytometry, animal model study | Liquid | 505701 505702 505703 | 1 mg 5 mg 20 mg | $175 $350 $700 | |||||||||
Antibodies | Spartalizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 505801 505802 505803 | 1 mg 5 mg 20 mg | $250 $750 $2000 | |||||||||
Antibodies | Tanezumab | Human IgG2 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 505901 505902 505903 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Tocilizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 506001 506002 506003 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Trastuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | 506101 506102 506103 506104 506105 | 1 mg 5 mg 20 mg 5 mg 20 mg | $125 $400 $800 $600 $1200 | |||||||||
Trastuzumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | Antibodies | Trastuzumab | Human IgG1, L234A L235A P329G (LALAPG) | Flow cytometry, animal model study | Liquid | 506201 | 1 mg | $650 | ||||||||
Antibodies | Trastuzumab | Human IgG1, N297A | Flow cytometry, animal model study | Liquid | 506301 | 1 mg | $650 | |||||||||
Antibodies | Tremelimumab | Human IgG2 | Flow cytometry, animal model study | Liquid | 506401 506402 506403 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Tusamitamab | Human IgG1 | Flow cytometry, animal model study | Liquid | 506501 506502 506503 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Ustekinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | 506601 506602 506603 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Zolbetuxima | Human IgG1 | Flow cytometry, animal model study | Liquid | 506701 506702 506703 | 1 mg 5 mg 20 mg | $175 $480 $960 | |||||||||
Antibodies | Eculizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | 506801 506802 506803 | 1 mg 5 mg 20 mg | $200 $750 $2200 |
